4.5 Review

MRI-based semiquantitative scoring of joint pathology in osteoarthritis

Journal

NATURE REVIEWS RHEUMATOLOGY
Volume 9, Issue 4, Pages 236-251

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrrheum.2012.223

Keywords

-

Categories

Ask authors/readers for more resources

The use of MRI techniques to investigate tissue pathology has become increasingly widespread in osteoarthritis (OA) research. Semiquantitative assessment of the joints by expert interpreters of MRI data is a powerful tool that can increase our understanding of the natural history of this complex disease. Several reliable and validated semiquantitative scoring systems now exist and have been applied to large-scale, multicentre, cross-sectional and longitudinal observational epidemiological studies. Such approaches have advanced our understanding of the associations of different tissue pathologies with pain and improved the definition of joint alterations that lead to disease progression. Semiquantitative MRI outcome measures have also been applied in several clinical trials in OA. Indeed, interest in MRI-based semiquantitative scoring systems has led to the development of several novel scoring systems that can be applied to different joints: a knee synovitis scoring system based on contrast-enhanced MRI; the MRI Osteoarthritis Knee Score (MOAKS); the Hip Osteoarthritis MRI Score (HOAMS); and the Oslo Hand Osteoarthritis MRI score (OHOA-MRI). Although these new scoring systems offer theoretical advantages over pre-existing systems, whether they offer actual superiority with regard to reliability, responsiveness and validity remains to be seen. Guermazi, A. et al. Nat. Rev. Rheumatol. 9, 236-251 (2013); published online 15 January 2013; doi:10.1038/nrrheum.2012.223

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Multivariable Modeling of Biomarker Data From the Phase I Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium

David J. Hunter, Leticia A. Deveza, Jamie E. Collins, Elena Losina, Jeffrey N. Katz, Michael C. Nevitt, John A. Lynch, Frank W. Roemer, Ali Guermazi, Michael A. Bowes, Erik B. Dam, Felix Eckstein, C. Kent Kwoh, Steve Hoffmann, Virginia B. Kraus

Summary: This study identifies the optimal combination of imaging and biochemical biomarkers for predicting knee osteoarthritis progression. These biomarkers have the potential to be used in future disease-modifying trials to select participants likely to experience progression of knee OA.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Presence of Magnetic Resonance Imaging-Defined Inflammation Particularly in Overweight and Obese Women Increases Risk of Radiographic Knee Osteoarthritis: The POMA Study

Frank W. Roemer, Ali Guermazi, Michael J. Hannon, Tomoko Fujii, Patrick Omoumi, David J. Hunter, Felix Eckstein, C. Kent Kwoh

Summary: Overweight and obese women have increased odds for developing radiographic OA, especially in the presence of inflammatory markers.

ARTHRITIS CARE & RESEARCH (2022)

Review Orthopedics

Structural phenotypes of knee osteoarthritis: potential clinical and research relevance

Frank W. Roemer, Mohamed Jarraya, Jamie E. Collins, C. Kent Kwoh, Daichi Hayashi, David J. Hunter, Ali Guermazi

Summary: Structural phenotypic stratification can lead to more targeted trial populations and personalized treatment recommendations for patients. Radiologists can define the risk of progression in a joint based on the predominant phenotype present at different disease stages.

SKELETAL RADIOLOGY (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

The Role of Speed and Possible Implications

Frank W. Roemer

RADIOLOGY (2023)

Article Rheumatology

Selection of Knees With Subsequent Cartilage Thickness Loss Based on Magnetic Resonance Imaging Semiquantitative Grading: Data From the Osteoarthritis Initiative Foundation for the National Institutes of Health Biomarker Cohort

Wolfgang Wirth, Susanne Maschek, Anna Wisser, Ali Guermazi, David J. J. Hunter, C. Kent Kwoh, Michael C. C. Nevitt, Felix Eckstein, Frank W. W. Roemer

Summary: This study investigates the association between MRI-based articular pathologies and subsequent cartilage thickness loss. It found that cartilage damage, bone marrow lesions, medial meniscus extrusion or damage, as well as the severity of cartilage and meniscus damage are predictive of progression in the medial femorotibial compartment. MRI assessment can help select appropriate participants for clinical trials and identify those who do not require treatment.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Development of a Magnetic Resonance Imaging-Based Definition of Knee Osteoarthritis: Data From the Multicenter Osteoarthritis Study

Jean. W. W. Liew, Gabriela Rabasa, Michael LaValley, Jamie Collins, Joshua Stefanik, Frank. W. W. Roemer, Ali Guermazi, Cora. E. E. Lewis, Michael Nevitt, James Torner, David Felson

Summary: This study tested the performance of different MRI definitions for knee osteoarthritis and found that an MRI definition requiring cartilage damage and a small osteophyte, with or without bone marrow lesions or synovitis, had the best performance and simplicity for identifying radiographic and symptomatic knee osteoarthritis.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Orthopedics

Worsening of Articular Tissue Damage as Defined by Semi-Quantitative MRI Is Associated With Concurrent Quantitative Cartilage Loss Over 24 Months

Frank Roemer, Susanne Maschek, Anna Wisser, Ali Guermazi, David Hunter, Felix Eckstein, Wolfgang Wirth

Summary: This study aimed to assess the association of worsening MRI semi-quantitative tissue features with concurrent change in quantitative cartilage thickness measurements. The study found that worsening cartilage damage, meniscal extrusion and damage, number of subregions affected by bone marrow lesions, maximal size of bone marrow lesions, and worsening effusion- and/or Hoffa synovitis were associated with increased cartilage loss.

CARTILAGE (2023)

Article Sport Sciences

Gait, physical activity and tibiofemoral cartilage damage: a longitudinal machine learning analysis in the Multicenter Osteoarthritis Study

Kerry E. Costello, David T. Felson, S. Reza Jafarzadeh, Ali Guermazi, Frank W. Roemer, Neil A. Segal, Cora E. Lewis, Michael C. Nevitt, Cara L. Lewis, Vijaya B. Kolachalama, Deepak Kumar

Summary: This study developed a machine learning model that incorporates gait and physical activity to predict medial tibiofemoral cartilage worsening over 2 years in individuals without advanced knee osteoarthritis. The model showed good performance in predicting cartilage worsening and identified influential predictors in the outcome.

BRITISH JOURNAL OF SPORTS MEDICINE (2023)

Review Orthopedics

Osteoarthritis year in review 2022: imaging

S. Demehri, A. Kasaeian, F. W. Roemer, A. Guermazi

Summary: This narrative review summarizes original research on imaging in osteoarthritis (OA) published between April 1st 2021 and March 31st 2022. The study only considered English publications that were in vivo human studies. The review highlights the anatomical focus of research on the structures within the tibiofemoral, patellofemoral, hip, and hand joints, as well as the use of artificial intelligence in OA imaging.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Orthopedics

MRI underestimates presence and size of knee osteophytes using CT as a reference standard

F. W. Roemer, K. Engelke, L. Li, J. -D. Laredo, A. Guermazi

Summary: This study aimed to investigate the diagnostic performance of routine MRI for assessing osteophytes in three knee compartments using CT as a reference standard. The study found that MRI underestimates the presence of osteophytes in all three compartments, and CT may be helpful in assessing small osteophytes, especially in early disease.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Orthopedics

Comparison of evaluation metrics of deep learning for imbalanced imaging data in osteoarthritis studies

Shen Liu, Frank Roemer, Yong Ge, Edward J. Bedrick, Zong-Ming Li, Ali Guermazi, Leena Sharma, Charles Eaton, Marc C. Hochberg, David J. Hunter, Michael C. Nevitt, Wolfgang Wirth, C. Kent Kwoh, Xiaoxiao Sun

Summary: This study compares the evaluation metrics for deep learning methods developed using imbalanced imaging data in osteoarthritis studies. It found that the commonly used ROC curve is not sufficiently informative in the case of imbalanced data. Practical suggestions are provided for different degrees of data imbalance.

OSTEOARTHRITIS AND CARTILAGE (2023)

Review Rheumatology

Comparative effectiveness of pharmacological interventions for hand osteoarthritis: a systematic review and network meta-analysis of randomised trials

Anna Dossing, Sabrina Mai Nielsen, Feline P. B. Kroon, Ida Maria Balsby, Simon Tarp, Margreet Kloppenburg, Lisa Stamp, Ida K. Haugen, Roy D. Altman, Marius Henriksen, Mikael Boesen, Henning Bliddal, Soren Berg, Robin Christensen

Summary: Oral NSAIDs and glucocorticoids are effective pharmacological interventions for hand osteoarthritis, while intra-articular therapies and topical NSAIDs are not superior to placebo.

RMD OPEN (2023)

Review Rheumatology

Role of imaging for eligibility and safety of a-NGF clinical trials

Frank W. W. Roemer, Marc C. C. Hochberg, John A. A. Carrino, Andrew J. J. Kompel, Luis Diaz, Daichi Hayashi, Michel D. D. Crema, Ali Guermazi

Summary: Inhibitors of nerve growth factor (a-NGF) have shown efficacy in pain treatment for symptomatic osteoarthritis (OA). However, concerns about accelerated OA progression led to the suspension of a-NGF clinical trials in 2010. Trials were resumed in 2015 with improved safety measures based on imaging. In 2021, the FDA advisory committee voted against approving a-NGF compound tanezumab due to insufficient risk evaluation and mitigation strategy. Future trials will require strict eligibility criteria and close safety monitoring.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2023)

Article Sport Sciences

Evidence of ACL healing on MRI following ACL rupture treated with rehabilitation alone may be associated with better patient-reported outcomes: a secondary analysis from the KANON trial

Stephanie Rose Filbay, Frank W. Roemer, L. Stefan Lohmander, Aleksandra Turkiewicz, Ewa M. Roos, Richard Frobell, Martin Englund

Summary: This study evaluated the natural course of ACL healing after ACL rupture within 5 years on MRI and compared the outcomes at 2 and 5 years based on healing status and treatment group. The results showed that ACL healing on MRI was associated with favorable outcomes, suggesting that the potential for spontaneous healing of the ACL may be greater than previously considered.

BRITISH JOURNAL OF SPORTS MEDICINE (2023)

Review Rheumatology

Latest advancements in imaging techniques in OA

Daichi Hayashi, Frank W. W. Roemer, Thomas Link, Xiaojuan Li, Feliks Kogan, Neil A. A. Segal, Patrick Omoumi, Ali Guermazi

Summary: The OA research community advocates for a shift from radiography-based criteria to MRI-based definition in OA clinical trials. Various evaluation tools and advanced technologies, including PET-MRI and AI, have been introduced in osteoarthritis imaging, aiming to improve precision and reproducibility in image interpretation.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2022)

No Data Available